SciELO - Scientific Electronic Library Online

 
vol.39Trastornos inmunitarios en paciente pediátrico con enfermedad de BehcetBasic zipper protein (HBZ): biomarcador diagnóstico y de seguimiento de leucemia/linfoma T del adulto índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista Cubana de Hematología, Inmunología y Hemoterapia

versão On-line ISSN 1561-2996

Resumo

RAMIREZ,GONZALEZ, Wendy et al. Immunogenicity and protective efficacy of variants of a novel PROLINEM DS anti-allergic vaccine. Rev Cubana Hematol Inmunol Hemoter [online]. 2023, vol.39  Epub 01-Maio-2023. ISSN 1561-2996.

Introduction:

The second generation anti allergic vaccine named PROLINEM DS is based on allergens from D. siboney house dust mite and a combination adjuvant containing PL and Alum. Allergen adsorption is relevant both safety and clinical efficacy in alum-adsorbed vaccines. Negative influence of phosphate ions on allergen adsorption was demonstrated in previous researches.

Objective:

To evaluate immunogenicity and protective efficacy of four variants obtained within design space of PROLINEM DS vaccine.

Methods:

Four variants were differentiated from each other by both phosphate and alum contents. Balb/c mice were administered with 3 doses by subcutaneous route. Further, mice were subjected to allergen aerosol challenge.

Results:

Specific IgG1 and IgG2a antibodies were induced by four vaccine variants. It was correlated with pro inflammatory cytokines balance Th1/Th2 both in lungs and lymphatic nodes. Formulation with lower PBS and Alum levels showed the highest IgG/IgE ratio at the end of vaccination schedule. This ratio shows in one variable the balance between potentially blocking and effector components. Mice injected with lower level of Alum showed a reduction of granuloma size in the site of vaccine administration.

Conclusion:

Decrease both alum and phosphate contents were a pharmaceutical improvement for antiallergic vaccines formulation. Safety and efficacy in this vaccine are crucial for future human clinical trials.

Palavras-chave : allergy immunotherapy; combination adjuvant; dust mite; design space; immunogenicity.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )